Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors
GHDx Entry last modified on: May 12, 2022
COVID-19
Dataset Records for COVID-19
Displaying 901 - 950 of 1228
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Preprint
GHDx Entry last modified on: May 12, 2022
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
GHDx Entry last modified on: Mar 14, 2022
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
GHDx Entry last modified on: Mar 14, 2022
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series
GHDx Entry last modified on: Mar 14, 2022
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
GHDx Entry last modified on: Mar 14, 2022
Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study
GHDx Entry last modified on: Feb 16, 2023
[Assessment of population immunity to SARS-CoV-2 among the population of the Leningrad region during the COVID-19 epidemic]
Оценкa популяционого имм унитета к SARS-CoV-2 среди населения Ленинградск ой области в период эпидемии COVID-19
Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
GHDx Entry last modified on: May 12, 2022
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
GHDx Entry last modified on: Mar 14, 2022
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic
GHDx Entry last modified on: Mar 14, 2022
Formation of Herd Immunity to SARS-CoV-2 in the Regions of Uzbekistan
GHDx Entry last modified on: May 12, 2022
[Seroepidemiological surveillance of SARS-CoV-2 circulation in 41 municipalities in Honduras with no report of active cases, COVID-19, June 16-23, 2020]
Vigilancia seroepidemiológica de la circulación del SARS-CoV-2 en 41 municipios de Honduras sin reporte de casos activos, COVID-19, del 16- 23 junio 2020
Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2-Specific Antibody Prevalence and Symptoms in a Local Austrian Population
GHDx Entry last modified on: Mar 14, 2022
Long COVID in children and adolescents
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study
GHDx Entry last modified on: Mar 14, 2022
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic
GHDx Entry last modified on: May 12, 2022
Seropositive coronavirus disease 2019 detection among apparently healthy voluntary blood donors: a preliminary step to catch asymptomatic cases as a potential viral spread route
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. Preprint
GHDx Entry last modified on: May 12, 2022
COVID-19 in pregnancy: A preliminary 50-day review from India
GHDx Entry last modified on: Sep 29, 2022
Systematic screening for SARS-CoV-2 in pregnant women admitted for delivery in a Portuguese maternity
GHDx Entry last modified on: Sep 29, 2022
Pregnancy outcomes of COVID-19 positive pregnant women at the Cantonal Hospital Zenica, Bosnia and Herzegovina
GHDx Entry last modified on: Sep 29, 2022
Clinical Features and Outcomes of COVID-19 Infection among Pregnant Women in South Africa
GHDx Entry last modified on: Sep 29, 2022
Association of SARS-CoV-2 Test Status and Pregnancy Outcomes
GHDx Entry last modified on: Sep 29, 2022
Development Assistance for COVID-19 Vaccine Delivery 2020-2021
GHDx Entry last modified on: Mar 16, 2023
Nepal Coronavirus Disease Prevention Map: Movement Between Administrative Regions - Facebook Data for Good
Geospatial data:
GPS coordinates (GIS)
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors
GHDx Entry last modified on: Mar 14, 2022
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak. Preprint
GHDx Entry last modified on: Mar 14, 2022
Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in-hospital mortality
GHDx Entry last modified on: Mar 14, 2022
Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020
GHDx Entry last modified on: Mar 14, 2022
Clinico-Radiological Features and Outcomes in Pregnant Women with COVID-19 Pneumonia Compared with Age-Matched Non-Pregnant Women
GHDx Entry last modified on: Mar 14, 2022
Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App
GHDx Entry last modified on: Mar 14, 2022
Maternal and neonatal outcomes in COVID-19 infected pregnancies: a prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan
GHDx Entry last modified on: Mar 14, 2022
[The experience of the study of seroprevalence to the SARS-CoV-2 virus in the population of the Irkutsk region during the COVID-19 outbreak]
Опыт исс ледования серопревалентности к вирусу SARS-CoV-2 населения Иркутск ой области в период вспышки COVID-19
Brazil - Severe Acute Respiratory Syndrome Database - including data from COVID-19 2020-2022
Severe Acute Respiratory Syndrome Database - including COVID-19 data
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany
GHDx Entry last modified on: Jun 17, 2021
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
GHDx Entry last modified on: Feb 10, 2022
Covid-19 during pregnancy: A case series from an universally tested population from the north of Portugal
GHDx Entry last modified on: Mar 14, 2022
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam
GHDx Entry last modified on: Mar 14, 2022
Subscribe